In line with the result of the present study, our previous study found that patients with IgM-MGRS (all 11 patients were included in this current study) were more likely to have renal dysfunction, hematuria, anemia and hypocomplementemia compared with those with IgG-MGRS and IgA-MGRS4. This evidence concerns the gene CD79A and anemia (phenotype).